Product name :ILOPERIDONE CAS No: 133454-47-4 Molecular Formula: C24H27FN2O4 Appearance: White to off-white crystalline powder Application: Atypical antipsychotics Package: according to the clients requirement Port: Shanghai Production Capacity: 500kg/month Purity: 99% Storage: Keep in cool, dry and sealed Transportation: by sea or by air MOQ:1kg

Product Details

Product name :ILOPERIDONE

CAS No: 133454-47-4

Molecular Formula: C24H27FN2O4

Appearance: White to off-white crystalline powder

Application: Atypical antipsychotics

Package: according to the clients requirement

Port: Shanghai

Production Capacity: 500kg/month

Purity: 99%

Storage: Keep in cool, dry and sealed

Transportation: by sea or by air




Product Description


As an oral atypical antipsychotic drug, epirenone has obvious effects on alleviating the positive symptoms (such as hallucination, delusion, thinking disorder, hostility and suspicion) and negative symptoms (such as slow reaction, indifferent mood, indifferent social interaction and lack of language) of patients with schizophrenia. As a 5-ht2 /D2 receptor antagonist, epirenone also has a high affinity for dopamine D3 receptor, an appropriate affinity for adrenaline a1 receptor, dopamine D4 receptor, 5-ht6 and 5-ht7, and a low affinity for 5-ht1a, dopamine D1 and histamine H1 receptor. Compared with the use of antipsychotic drugs, short-term and long-term safety test results show that the Pan Li ketone of less adverse reactions, patients' body quality increase amplitude is small, the Pan Li ketone wont happen induction in patients with diabetes, extrapyramidal symptoms in patients with less (such as akathisia, incidence of high blood prolactin, sleepiness, drop, less cognitive decline, etc.). Clinical study results showed that epirenone had good safety and tolerance, good metabolism, and was mainly excreted through liver metabolism. The most common adverse reactions were dizziness, dry mouth, fatigue, nasal congestion, postural hypotension, lethargy, increased heart rate, increased body mass and prolonged QT interval. Epirenone can increase the risk of death in patients with alzheimer's disease, so it should not be used in patients with alzheimer's disease.